Salvage therapy high-dose chemotherapy autologous bone marrow support treatment primary nonseminomatous mediastinal germ cell tumors authors experience use high-dose chemotherapy autologous bone marrow rescue ABMR salvage therapy treatment patients recurrent refractory primary nonseminomatous mediastinal germ cell tumors PMGCT authors patients PMGCT high-dose carboplatin patients ifosfamide ABMR Patients second relapse cisplatin refractory progression weeks last cisplatin median prior chemotherapy regimens range prior cisplatin therapy ifosfamide-based therapy patients cisplatin refractory partial response PR short duration patients rounds therapy patients courses remainder round therapy inadequate response patients excessive toxicity patients patients peritransplant period due patients patients median survival group days range days days patient complete remission partial remissions stable disease progressive disease use high-dose carboplatin etoposide ifosfamide ABMR effective treatment group patients PMGCT second relapse cisplatin refractory 